Discover how we collaborated with the UroCCR network to develop a machine learning model that outperformed the predictive performance of most usual kidney cancer risk scores.
Did you miss our ASHG symposium? Don’t fret! Read our recap of how renowned genomic experts saved time, reduced costs, and improved the yield of their hereditary cancer and rare disease workflows using SOPHiA DDM™ combined with Alamut™ Visual Plus.
Read about our successful collaborations, Dr Terracciano’s favorite SOPHiA DDM™ Platform features, and what she sees in the future for SOPHiA GENETICS.
Larger panels may cast wider nets, but optimization with patented algorithms through our universal platform gives more actionable insights without sacrificing data quality.
2021 has been a big year for SOPHiA GENETICS. Here’s a recap of some of the major highlights…
Newsletter updates for March 2021
